Status:
UNKNOWN
The Prevalence of Serum Thyroid Hormone Autoantibodies in Autoimmune Thyroid Diseases
Lead Sponsor:
Shandong Provincial Hospital
Conditions:
Autoimmune Thyroid Disease
Eligibility:
All Genders
18-65 years
Brief Summary
Thyroid hormone autoantibodies(THAA) in serum can Interfere radioimmunoassay for the determination of free thyroid hormones. Thyroid function test plays a key role in the diagnosis and treatment of au...
Eligibility Criteria
Inclusion
- male or female with Hashimoto thyroiditis or Grave's disease aged for 18 to 65 years old
Exclusion
- Had a thyroidectomy Had a thyroid fine needle puncture biopsy Autoimmune diseases Take drugs that affect the immune system
Key Trial Info
Start Date :
August 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2022
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT04075851
Start Date
August 1 2019
End Date
August 1 2022
Last Update
April 14 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shandong Province Hospital
Jinan, Shandong, China, 250021